We focus exclusively on financing rigorously selected healthcare products that are close to market launch. These are typically diagnostic tests, medical devices or e-solutions.
We bring significant value by working closely with each team on the clinical study design, the market access strategy and all communication aspects.
Our success is closely linked to the commercial success of each product because we will receive a percentage of the overall annual royalties paid to investors. Thus, we have a vested interest in selecting quality projects and products.
Selection of projects with high potential of commercial success
Operational long-term collaboration
Market access and communication
To be a catalyst of the commercial success of innovative healthcare products
Accelerate the launch of each product by providing the expertise and the funding required
• Rigorous project selection
• Operational contribution
• Long-term commitment